Simon April-Monn

525 total citations
8 papers, 364 citations indexed

About

Simon April-Monn is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Simon April-Monn has authored 8 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Simon April-Monn's work include Neuroendocrine Tumor Research Advances (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Neuroblastoma Research and Treatments (2 papers). Simon April-Monn is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Neuroblastoma Research and Treatments (2 papers). Simon April-Monn collaborates with scholars based in Switzerland, Germany and Italy. Simon April-Monn's co-authors include Gregor-Alexander Pilz, Sebastian Jessberger, Marion Betizeau, Stefano Carta, Benjamin D. Simons, Fritjof Helmchen, David J. Jörg, Ilaria Marinoni, Massimo Falconi and Aurel Perren and has published in prestigious journals such as Science, Nature Communications and Cell Death and Differentiation.

In The Last Decade

Simon April-Monn

8 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon April-Monn Switzerland 6 176 145 88 63 51 8 364
Germán Belenguer Spain 10 144 0.8× 206 1.4× 63 0.7× 45 0.7× 39 0.8× 16 477
April Kemper United States 6 161 0.9× 188 1.3× 112 1.3× 67 1.1× 29 0.6× 8 502
Sarrabeth Stone United States 15 63 0.4× 209 1.4× 66 0.8× 61 1.0× 99 1.9× 20 561
Terra J. Frederick United States 6 183 1.0× 171 1.2× 72 0.8× 31 0.5× 21 0.4× 7 428
Bernadette Bellette Australia 12 101 0.6× 259 1.8× 160 1.8× 39 0.6× 15 0.3× 13 517
Marta Pellegatta Italy 10 100 0.6× 141 1.0× 262 3.0× 51 0.8× 22 0.4× 15 426
Carolina Serrano Mexico 8 86 0.5× 190 1.3× 77 0.9× 18 0.3× 36 0.7× 12 349
Do-Hun Lee United States 8 159 0.9× 143 1.0× 256 2.9× 27 0.4× 14 0.3× 9 474
Sébastien Gillotin United Kingdom 10 151 0.9× 374 2.6× 74 0.8× 70 1.1× 15 0.3× 12 457
Fernanda Gubert Brazil 13 133 0.8× 235 1.6× 153 1.7× 20 0.3× 14 0.3× 28 493

Countries citing papers authored by Simon April-Monn

Since Specialization
Citations

This map shows the geographic impact of Simon April-Monn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon April-Monn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon April-Monn more than expected).

Fields of papers citing papers by Simon April-Monn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon April-Monn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon April-Monn. The network helps show where Simon April-Monn may publish in the future.

Co-authorship network of co-authors of Simon April-Monn

This figure shows the co-authorship network connecting the top 25 collaborators of Simon April-Monn. A scholar is included among the top collaborators of Simon April-Monn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon April-Monn. Simon April-Monn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
April-Monn, Simon, Philipp Kirchner, Katharina Detjen, et al.. (2024). Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies. npj Precision Oncology. 8(1). 59–59. 4 indexed citations
2.
April-Monn, Simon, Daniel Helbling, Massimo Falconi, et al.. (2022). Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects. Cancers. 14(22). 5481–5481. 5 indexed citations
3.
Zindel, Joël, J. M. Bayer, Simon April-Monn, et al.. (2021). Intraperitoneal microbial contamination drives post-surgical peritoneal adhesions by mesothelial EGFR-signaling. Nature Communications. 12(1). 7316–7316. 46 indexed citations
4.
April-Monn, Simon, Valentina Andreasi, Marco Schiavo Lena, et al.. (2021). EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs). Cancers. 13(19). 5014–5014. 17 indexed citations
5.
Dettwiler, Martina, Kerstin Hahn, Simon April-Monn, et al.. (2021). Validation of Immunohistochemistry for Canine Proteins Involved in Thyroid Iodine Uptake and Their Expression in Canine Follicular Cell Thyroid Carcinomas (FTCs) and FTC-Derived Organoids. Veterinary Pathology. 58(6). 1172–1180. 14 indexed citations
6.
April-Monn, Simon, Tabea Wiedmer, Renaud Maire, et al.. (2020). Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 111(3). 273–287. 38 indexed citations
7.
Pilz, Gregor-Alexander, Marion Betizeau, David J. Jörg, et al.. (2018). Live imaging of neurogenesis in the adult mouse hippocampus. Science. 359(6376). 658–662. 231 indexed citations
8.
He, Zhaoyue, Simon April-Monn, Marcel P. Trefny, et al.. (2018). Biochemical re-programming of human dermal stem cells to neurons by increasing mitochondrial membrane potential. Cell Death and Differentiation. 26(6). 1048–1061. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026